FDA Biologics (BLA & Biosimilars)Original article
FDA Roundtable: Strengthening the Supply Chain for Blood Manufacturing - 09/29/2026
Neutral
AI Analysis
Summary
The FDA's Center for Biologics Evaluation and Research is hosting a roundtable on September 29, 2026 to discuss strengthening the supply chain for blood collection, manufacturing, and transfusion operations.
Importance:2/10
Sentiment:
0.00
FDARegulatoryBlood ManufacturingSupply ChainRoundtable
Read the original article
Published by FDA Biologics (BLA & Biosimilars) on September 11, 2026 4:37 PM